Recherche PDF


Cet outil permet de trouver un fichier parmi les documents publics partagés par les utilisateurs de Fichier-PDF.fr.
Dernière mise à jour de la base de données: 04 décembre à 04:54 - Environ 390000 fichiers indexés.

Afficher résultats par page

Réponses pour «failure»:



Total: 700 résultats - 0.105 secondes

Acute Decomp Heart Failure 100%

Acute Decompensated Heart Failure:

https://www.fichier-pdf.fr/2017/08/03/acute-decomp-heart-failure/

03/08/2017 www.fichier-pdf.fr

The Vaccine Adverse Event Reporting System (VAERS) Results Form (1) 95%

The Vaccine Adverse Event Reporting System (VAERS) Results Form (1) 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form CDC WONDER FAQs Help Contact Us WONDER Search The Vaccine Adverse Event Reporting System (VAERS) Results Year Died Vaccine Type ABDOMEN SCAN 2021 COVID19 VACCINE (COVID19) ABDOMEN SCAN 2021 Symptoms Total ABDOMEN SCAN ABDOMINAL DISCOMFORT 2021 ABDOMINAL DISCOMFORT 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISCOMFORT ABDOMINAL DISTENSION 2021 ABDOMINAL DISTENSION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL DISTENSION ABDOMINAL EXPLORATION 2021 ABDOMINAL EXPLORATION 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL EXPLORATION ABDOMINAL HERNIA 2021 ABDOMINAL HERNIA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL HERNIA ABDOMINAL INJURY 2021 ABDOMINAL INJURY 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL INJURY ABDOMINAL MASS 2021 ABDOMINAL MASS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL MASS ABDOMINAL PAIN 2021 ABDOMINAL PAIN 2021 ABDOMINAL PAIN Unknown Date ABDOMINAL PAIN Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN ABDOMINAL PAIN LOWER 2021 ABDOMINAL PAIN LOWER 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN LOWER ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER 2021 ABDOMINAL PAIN UPPER Unknown Date ABDOMINAL PAIN UPPER Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL PAIN UPPER ABDOMINAL SEPSIS 2021 ABDOMINAL SEPSIS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL SEPSIS ABDOMINAL TENDERNESS 2021 ABDOMINAL TENDERNESS 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL TENDERNESS ABDOMINAL WALL HAEMATOMA 2021 ABDOMINAL WALL HAEMATOMA 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMATOMA ABDOMINAL WALL HAEMORRHAGE 2021 ABDOMINAL WALL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ABDOMINAL WALL HAEMORRHAGE ABDOMINAL WALL OEDEMA Total 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 29 0.42% 29 0.42% 29 0.42% 26 0.37% 26 0.37% 26 0.37% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 115 1.65% 115 1.65% 3 0.04% 3 0.04% 118 1.69% 11 0.16% 11 0.16% 11 0.16% 57 0.82% 57 0.82% 5 0.07% 5 0.07% 62 0.89% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms ABDOMINAL WALL OEDEMA Year Died Vaccine Type Total 2021 Total ABDOMINAL WALL OEDEMA ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY 2021 ABDOMINAL X-RAY Unknown Date ABDOMINAL X-RAY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ABDOMINAL X-RAY ABNORMAL BEHAVIOUR 2021 ABNORMAL BEHAVIOUR 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL BEHAVIOUR ABNORMAL FAECES 2021 ABNORMAL FAECES 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL FAECES ABNORMAL SLEEP-RELATED EVENT 2021 ABNORMAL SLEEP-RELATED EVENT 2021 COVID19 VACCINE (COVID19) Total Total ABNORMAL SLEEP-RELATED EVENT ABSCESS DRAINAGE 2021 ABSCESS DRAINAGE 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS DRAINAGE ABSCESS LIMB 2021 ABSCESS LIMB 2021 COVID19 VACCINE (COVID19) Total Total ABSCESS LIMB ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 2021 COVID19 VACCINE (COVID19) Total Total ABSENCE OF IMMEDIATE TREATMENT RESPONSE ABSTAINS FROM ALCOHOL 2021 ABSTAINS FROM ALCOHOL 2021 COVID19 VACCINE (COVID19) Total Total ABSTAINS FROM ALCOHOL ACCIDENT 2021 ACCIDENT 2021 COVID19 VACCINE (COVID19) Total Total ACCIDENT ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE 2021 ACCIDENTAL OVERDOSE Unknown Date ACCIDENTAL OVERDOSE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACCIDENTAL OVERDOSE ACIDOSIS 2021 ACIDOSIS 2021 COVID19 VACCINE (COVID19) Total Total ACIDOSIS ACQUIRED OESOPHAGEAL WEB 2021 ACQUIRED OESOPHAGEAL WEB 2021 COVID19 VACCINE (COVID19) Total Total ACQUIRED OESOPHAGEAL WEB ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ACTIVATED PARTIAL THROMBOPLASTIN TIME NORMAL ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 7 0.10% 7 0.10% 4 0.06% 4 0.06% 11 0.16% 29 0.42% 29 0.42% 29 0.42% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 6 0.09% 6 0.09% 6 0.09% 1 0.01% 1 0.01% 1 0.01% 3 0.04% 3 0.04% 3 0.04% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 19 0.27% 19 0.27% 19 0.27% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 7 0.10% 7 0.10% 2/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Symptoms Year Died ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED Vaccine Type Total ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED 2021 ACTIVATED PARTIAL THROMBOPLASTIN TIME SHORTENED COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN 2021 ACUTE ABDOMEN 2021 COVID19 VACCINE (COVID19) Total Total ACUTE ABDOMEN ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT 2021 ACUTE CARDIAC EVENT Unknown Date ACUTE CARDIAC EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE CARDIAC EVENT ACUTE CHEST SYNDROME 2021 ACUTE CHEST SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CHEST SYNDROME ACUTE CORONARY SYNDROME 2021 ACUTE CORONARY SYNDROME 2021 COVID19 VACCINE (COVID19) Total Total ACUTE CORONARY SYNDROME ACUTE HEPATIC FAILURE 2021 ACUTE HEPATIC FAILURE 2021 COVID19 VACCINE (COVID19) Total Total ACUTE HEPATIC FAILURE ACUTE INTERSTITIAL PNEUMONITIS 2021 ACUTE INTERSTITIAL PNEUMONITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE INTERSTITIAL PNEUMONITIS ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY 2021 ACUTE KIDNEY INJURY Unknown Date ACUTE KIDNEY INJURY Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE KIDNEY INJURY ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE 2021 ACUTE LEFT VENTRICULAR FAILURE Unknown Date ACUTE LEFT VENTRICULAR FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE LEFT VENTRICULAR FAILURE ACUTE MYELOID LEUKAEMIA 2021 ACUTE MYELOID LEUKAEMIA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE MYELOID LEUKAEMIA ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION 2021 ACUTE MYOCARDIAL INFARCTION Unknown Date ACUTE MYOCARDIAL INFARCTION Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE MYOCARDIAL INFARCTION ACUTE PULMONARY OEDEMA 2021 ACUTE PULMONARY OEDEMA 2021 COVID19 VACCINE (COVID19) Total Total ACUTE PULMONARY OEDEMA ACUTE RESPIRATORY DISTRESS SYNDROME 2021 ACUTE RESPIRATORY DISTRESS SYNDROME 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 7 0.10% 10 0.14% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 1 0.01% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 2 0.03% 2 0.03% 2 0.03% 9 0.13% 9 0.13% 9 0.13% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 267 3.82% 267 3.82% 9 0.13% 9 0.13% 276 3.95% 10 0.14% 10 0.14% 1 0.01% 1 0.01% 11 0.16% 9 0.13% 9 0.13% 9 0.13% 104 1.49% 104 1.49% 5 0.07% 5 0.07% 109 1.56% 4 0.06% 4 0.06% 4 0.06% 64 0.92% 64 0.92% 3/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date COVID19 VACCINE (COVID19) ACUTE RESPIRATORY DISTRESS SYNDROME Unknown Date Symptoms Total Total ACUTE RESPIRATORY DISTRESS SYNDROME ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE 2021 ACUTE RESPIRATORY FAILURE Unknown Date ACUTE RESPIRATORY FAILURE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ACUTE RESPIRATORY FAILURE ACUTE SINUSITIS 2021 ACUTE SINUSITIS 2021 COVID19 VACCINE (COVID19) Total Total ACUTE SINUSITIS ADAMTS13 ACTIVITY NORMAL 2021 ADAMTS13 ACTIVITY NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ADAMTS13 ACTIVITY NORMAL ADENOCARCINOMA 2021 ADENOCARCINOMA 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA ADENOCARCINOMA METASTATIC 2021 ADENOCARCINOMA METASTATIC 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA METASTATIC ADENOCARCINOMA OF COLON 2021 ADENOCARCINOMA OF COLON 2021 COVID19 VACCINE (COVID19) Total Total ADENOCARCINOMA OF COLON ADENOVIRUS TEST 2021 ADENOVIRUS TEST 2021 COVID19 VACCINE (COVID19) Total Total ADENOVIRUS TEST ADJUSTED CALCIUM 2021 ADJUSTED CALCIUM 2021 COVID19 VACCINE (COVID19) Total Total ADJUSTED CALCIUM ADRENAL HAEMORRHAGE 2021 ADRENAL HAEMORRHAGE 2021 COVID19 VACCINE (COVID19) Total Total ADRENAL HAEMORRHAGE ADULT FAILURE TO THRIVE 2021 ADULT FAILURE TO THRIVE 2021 COVID19 VACCINE (COVID19) Total Total ADULT FAILURE TO THRIVE ADVERSE DRUG REACTION Unknown Date ADVERSE DRUG REACTION Unknown Date COVID19 VACCINE (COVID19) Total Total ADVERSE DRUG REACTION ADVERSE EVENT 2021 ADVERSE EVENT 2021 ADVERSE EVENT Unknown Date ADVERSE EVENT Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT ADVERSE EVENT FOLLOWING IMMUNISATION 2021 ADVERSE EVENT FOLLOWING IMMUNISATION 2021 COVID19 VACCINE (COVID19) Total Total ADVERSE EVENT FOLLOWING IMMUNISATION ADVERSE REACTION Unknown Date ADVERSE REACTION Unknown Date ADVERSE REACTION https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Total Events Reported Percent (of 6,981) 4 0.06% 4 0.06% 68 0.97% 255 3.65% 255 3.65% 4 0.06% 4 0.06% 259 3.71% 2 0.03% 2 0.03% 2 0.03% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 3 0.04% 8 0.11% 8 0.11% 8 0.11% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 4 0.06% 1 0.01% 1 0.01% 1 0.01% 2 0.03% 2 0.03% 2 0.03% 4/179 28/09/2021 06:45 The Vaccine Adverse Event Reporting System (VAERS) Results Form Year Died Vaccine Type AFFECT LABILITY 2021 COVID19 VACCINE (COVID19) AFFECT LABILITY 2021 Symptoms Total Total AFFECT LABILITY AGEUSIA 2021 AGEUSIA 2021 AGEUSIA Unknown Date AGEUSIA Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total AGEUSIA AGGRESSION 2021 AGGRESSION 2021 COVID19 VACCINE (COVID19) Total Total AGGRESSION AGITATION 2021 AGITATION 2021 COVID19 VACCINE (COVID19) Total Total AGITATION AGONAL DEATH STRUGGLE 2021 AGONAL DEATH STRUGGLE 2021 COVID19 VACCINE (COVID19) Total Total AGONAL DEATH STRUGGLE AGONAL RESPIRATION 2021 AGONAL RESPIRATION 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RESPIRATION AGONAL RHYTHM 2021 AGONAL RHYTHM 2021 COVID19 VACCINE (COVID19) Total Total AGONAL RHYTHM AIRWAY PATENCY DEVICE INSERTION 2021 AIRWAY PATENCY DEVICE INSERTION 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY PATENCY DEVICE INSERTION AIRWAY SECRETION CLEARANCE THERAPY 2021 AIRWAY SECRETION CLEARANCE THERAPY 2021 COVID19 VACCINE (COVID19) Total Total AIRWAY SECRETION CLEARANCE THERAPY ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE 2021 ALANINE AMINOTRANSFERASE Unknown Date ALANINE AMINOTRANSFERASE Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE ALANINE AMINOTRANSFERASE DECREASED 2021 ALANINE AMINOTRANSFERASE DECREASED 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE DECREASED ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED 2021 ALANINE AMINOTRANSFERASE INCREASED Unknown Date ALANINE AMINOTRANSFERASE INCREASED Unknown Date COVID19 VACCINE (COVID19) Total COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE INCREASED ALANINE AMINOTRANSFERASE NORMAL 2021 ALANINE AMINOTRANSFERASE NORMAL 2021 COVID19 VACCINE (COVID19) Total Total ALANINE AMINOTRANSFERASE NORMAL ALBUMIN GLOBULIN RATIO 2021 ALBUMIN GLOBULIN RATIO 2021 COVID19 VACCINE (COVID19) Total Total ALBUMIN GLOBULIN RATIO ALBUMIN GLOBULIN RATIO ABNORMAL 2021 ALBUMIN GLOBULIN RATIO ABNORMAL 2021 https://wonder.cdc.gov/controller/datarequest/D8;jsessionid=866667CA39C46D5DE8D7506788CC COVID19 VACCINE (COVID19) Total Events Reported Percent (of 6,981) 1 0.01% 1 0.01% 1 0.01% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 25 0.36% 9 0.13% 9 0.13% 9 0.13% 24 0.34% 24 0.34% 24 0.34% 1 0.01% 1 0.01% 1 0.01% 22 0.32% 22 0.32% 22 0.32% 5 0.07% 5 0.07% 5 0.07% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 2 0.03% 3 0.04% 3 0.04% 1 0.01% 1 0.01% 4 0.06% 2 0.03% 2 0.03% 2 0.03% 38 0.54% 38 0.54% 1 0.01% 1 0.01% 39 0.56% 17 0.24% 17 0.24% 17 0.24% 3 0.04% 3 0.04% 3 0.04% 1 0.01% 1 0 01% 5/179

https://www.fichier-pdf.fr/2021/09/28/the-vaccine-adverse-event-reporting-system-vaers-results-form-1/

28/09/2021 www.fichier-pdf.fr

biblio covid19 4 94%

BIBLIOGRAPHIE RECHERCHE COVID 19 NEPHROLOGIE 25 MARS 2020 PR ALEXANDRE KARRAS, DR AURELIEN LORTHIOIR, DR OLIVIA LENOIR, PR PATRICK BRUNEVAL, HÔPITAL EUROPEEN GEORGES POMPIDOU JOURNAL TITRE PRINCIPALE POINTS CLES AUTEUR Bo Diao MedRxiv 4th March 2020 QUESTION Human Kidney is a Target for Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) Infection - 27.06% (23/85) patients exhibited acute renal Is the kidney a target of SARS failure (ARF).

https://www.fichier-pdf.fr/2020/03/26/bibliocovid194/

26/03/2020 www.fichier-pdf.fr

Rapid Fat loss training plan for women--------1 91%

DAY 1 - Legs and Abs Legs 1 4 Squat 2 4 sets, 6 – 10 reps 4 sets, 8 reps Dumbbell Lunge 5 3 sets, 12 (each leg) 3 sets, 6-8 reps 25 | USN BODY MAKEOVER RAISED DUMBBELL LUNGE Standing Hamstring Curl (theraband) 3 Seated Leg Extension (theraband) 2 sets, 12 reps 6 Standing calf raises 4 sets, 12,12,20,20 reps abs 7 Abductor raises 8 crunch and oblique twist to failure cardio 9 30-45 minutes of high intensity running/sprints or elliptical cycle.

https://www.fichier-pdf.fr/2015/02/11/rapid-fat-loss-training-plan-for-women-1/

11/02/2015 www.fichier-pdf.fr

Massmaterials.com 91%

MMR specializes in the practical application of Materials Testing, Materials Engineering, Failure Analysis and Forensic Engineering.

https://www.fichier-pdf.fr/2015/11/12/massmaterials-com/

12/11/2015 www.fichier-pdf.fr

GRR17 Report web 91%

see Appendix A for the full name and description Failed and failing states Oil and gas price spike Chronic disease, developed world Oil price shock China economic hard landing Asset price collapse 2nd Retrenchment from globalization (developed) Slowing Chinese economy (<6%) Oil and gas price spike Pandemics Asset price collapse Retrenchment from globalization Interstate and civil wars Pandemics Oil price shock 1st 2nd Asset price collapse 2010 Global governance gaps infrastructure Fiscal crises Breakdown of critical information Chronic disease Slowing Chinese economy (<6%) Fiscal crises Chronic disease Oil and gas price spike Retrenchment from globalization (developed) Economic Fiscal crises infrastructure Chronic disease Breakdown of critical information Oil price spikes Retrenchment from globalization (developed) Breakdown of critical information infrastructure Asset price collapse 2009 Retrenchment from globalization (emerging) Global governance gaps Chronic disease Slowing Chinese economy (<6%) 2011 Environmental Extreme energy price volatility Asset price collapse Geopolitical conflict Climate change Fiscal crises 2011 Climate change Biodiversity loss Corruption Flooding Storms and cyclones 2012 Geopolitical Extreme volatility in energy and agriculture prices imbalances Food shortage crises Water supply crises Major systemic financial failure 2012 Water supply crises Cyber attacks Rising greenhouse gas emissions Chronic fiscal imbalances Severe income disparity 2013 Societal Failure of climatechange mitigation and adaptation Diffusion of weapons of mass destruction Chronic fiscal imbalances Water supply crises Major systemic financial failure 2013 Mismanagement of population ageing Water supply crises Rising greenhouse gas emissions Chronic fiscal imbalances Severe income disparity 2014 Technological Critical information infrastructure breakdown Unemployment and underemployment Water crises Climate change Fiscal crises 2014 Cyber attacks Climate change Unemployment and underemployment Extreme weather events Income disparity 2015 Failure of climatechange mitigation and adaptation Interstate conflict with regional consequences Weapons of mass destruction Rapid and massive spread of infectious diseases Water crises 2015 High structural unemployment or underemployment State collapse or crisis Failure of national governance Extreme weather events Interstate conflict with regional consequences 2016 Severe energy price shock Large-scale involuntary migration Water crises Weapons of mass destruction Failure of climatechange mitigation and adaptation 2016 Major natural catastrophes Interstate conflict with regional consequences Failure of climatechange mitigation and adaptation Extreme weather events Large-scale involuntary migration 2017 Failure of climatechange mitigation and adaptation Major natural disasters Water crises Extreme weather events Weapons of mass destruction 2017 Massive incident of data fraud/theft Large-scale terrorist attacks Major natural disasters Large-scale involuntary migration Extreme weather events Source:

https://www.fichier-pdf.fr/2017/08/03/grr17-report-web/

03/08/2017 www.fichier-pdf.fr

004 OMD7 Brochure 90%

Shipping hipping vale Shipping (ABS) (BV) (CCS) (DNV) (GL) (KRS) (LR) (NKK) (PRS) (RINA) (RRS) (DNV) (GL) (KRS) (LR) (NKK) (PRS) (RINA) (RRS) Areas of Failure – 2 Stroke Engine Piston Rod Seal Cross Head Slides High temperatures, in excess of 200ºC that occur on bearing surfaces under initial failure conditions, can lead to a rapid Build-up of oil mist The possible result – generation of oil vapour.

https://www.fichier-pdf.fr/2016/08/26/004-omd7-brochure/

26/08/2016 www.fichier-pdf.fr

Materials Testing Online 90%

Failure Analysis, Materials Engineering &

https://www.fichier-pdf.fr/2015/11/04/materials-testing-online/

04/11/2015 www.fichier-pdf.fr

audi r8 part1 88%

2029773/4 Release date: 04-Sep-2012 Customer statement / workshop findings Poor idle, rough running, knocking noise, lack of power, oil leak, excessive smoke Technical background Although areas such as improved fuel consumption and reduced exhaust emissions are at the forefront of powertrain development, it is also important to any manufacturer to understand the reasons behind mechanical engine failure.

https://www.fichier-pdf.fr/2015/05/12/audi-r8-part1/

12/05/2015 www.fichier-pdf.fr

Recommandations patho cardio sport 88%

Allied Professions (ACNAP), European Association of Cardiovascular Imaging (EACVI), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Heart Failure Association (HFA).

https://www.fichier-pdf.fr/2021/01/24/recommandations-patho-cardio-sport/

24/01/2021 www.fichier-pdf.fr

91 cel 88%

METER] S6 STOP LIGHT SW [E] 14 IE1 1 13 G-W [D] [H] I5 Y-G L (S/D) G-W [F] G-W TO ABS ECU 7 L4 LIGHT FAILURE SENSOR 8 DELAY CIRCUIT 11 G [L] 1 H17 HIGH MOUNTED STOP LIGHT W-B W-B B18 W-B 1 BV1 BO 50 [M] BL [N] 24 CELICA (EWD403F) W-B 2 W-B 3 [K] (SHIELDED) R6 STOP LIGHT RH [REAR COMB.

https://www.fichier-pdf.fr/2015/11/25/91-cel/

25/11/2015 www.fichier-pdf.fr

High Flow oxygen therapy-bronchiolitis 87%

Infants in the standard-therapy group could receive rescue high-flow oxygen therapy if their condition met criteria for treatment failure.

https://www.fichier-pdf.fr/2018/04/06/high-flow-oxygen-therapy-bronchiolitis/

06/04/2018 www.fichier-pdf.fr

Design Analysis and Life Estimation 86%

From the above criteria the failure of a First Stage rotor blade leads to callastropic effect.

https://www.fichier-pdf.fr/2018/02/05/design-analysis-and-life-estimation/

05/02/2018 www.fichier-pdf.fr

P746 NRJED111065EN 85%

Feeder Feeder CT CT CB CB Q Q Q The MiCOM P746 also incorporates the main circuit breaker failure logic together with additional protection functions (Dead zone, overcurrent, etc...).

https://www.fichier-pdf.fr/2012/08/07/p746-nrjed111065en/

07/08/2012 www.fichier-pdf.fr

13344 85%

This is especially true for orbital missions, where a failure would devastate this fragile emerging industry for years to come.

https://www.fichier-pdf.fr/2012/06/18/13344/

18/06/2012 www.fichier-pdf.fr

Lean muscle gain training programme for men(2) (1) 85%

If you reach failure before you can complete the set, lower the training weight by 20- 30%, and continue until failure occurs.

https://www.fichier-pdf.fr/2015/02/11/lean-muscle-gain-training-programme-for-men-2-1/

11/02/2015 www.fichier-pdf.fr

wizardspells 85%

Failure.

https://www.fichier-pdf.fr/2011/11/06/wizardspells/

06/11/2011 www.fichier-pdf.fr

InternetX-Factor 85%

Failure is their only option and they don’t even suspect.

https://www.fichier-pdf.fr/2016/03/19/internetx-factor/

19/03/2016 www.fichier-pdf.fr

DIAGNOSISOFBROKENROTORBARSININDUCTIONMOTOR2 83%

The use of conditional monitoring allows maintenance to be scheduled, or other actions to be taken to prevent failure and avoid its aftermaths.

https://www.fichier-pdf.fr/2018/02/05/diagnosisofbrokenrotorbarsininductionmotor2/

05/02/2018 www.fichier-pdf.fr

ATR72-500 83%

Minimum control speed on the ground from which a sudden failure of the critical engine can be controlled by use of primary flight controls only, with the other engine operating at RTO power V1:

https://www.fichier-pdf.fr/2016/09/04/atr72-500-1/

04/09/2016 www.fichier-pdf.fr

Mooring Integrity LE BEON MANUFACTURING DOT 2014-79 82%

An “issue” can be a mooring system damage (only one line impacted, no direct consequence to production) or a mooring system failure (two or more lines impacted, causing production shut down and potentially damages to riser system).

https://www.fichier-pdf.fr/2014/11/10/mooring-integrity-le-beon-manufacturing-dot-2014-79/

10/11/2014 www.fichier-pdf.fr

HALLIBURTON 82%

when tool failure is suspected to be caused by température changes 7.

https://www.fichier-pdf.fr/2016/03/30/halliburton-1/

30/03/2016 www.fichier-pdf.fr

US contest rules bebopyourworld#2 24.07.2015 81%

Failure to timely submit all required information in the manner required in these Official Rules and/or any entry may result in disqualification.

https://www.fichier-pdf.fr/2015/07/24/us-contest-rules-bebopyourworld-2-24-07-2015/

24/07/2015 www.fichier-pdf.fr

English contest rules bebopyourworld#24.03.2015 81%

Failure to timely submit all required information in the manner required in these Official Rules and/or any entry may result in disqualification.

https://www.fichier-pdf.fr/2015/07/24/english-contest-rules-bebopyourworld-24-03-2015/

24/07/2015 www.fichier-pdf.fr